AI helping in early cancer detection via genomics solutions, data analytics

Indian hospitals are increasingly integrating artificial intelligence (AI) into cancer care which aids in early detection, diagnosis accuracy, personalised treatments, and patient outcomes, according to experts.

Bengaluru-based Strand Life Sciences, a Reliance Industries subsidiary, partnered with Agilent, Celemics, and SOPHiA Genetics to enhance cancer care through AI. The company said AI improves early melanoma detection by distinguishing benign from malignant skin lesions.